Integrating bioinformatics and machine learning to discover sumoylation associated signatures in sepsis. [PDF]
Teng X, Wang Q, Ma J, Li D.
europepmc +1 more source
Problemas en la vestimenta en personas con discapacidad
Iván Barrios, Aaron Genes
doaj
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé+7 more
wiley +1 more source
Network-Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple-Negative Breast Cancer. [PDF]
Singh P, Chaturvedi R, Somvanshi P.
europepmc +1 more source
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM
CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak+14 more
wiley +1 more source
Evolution of Genes and Genes in Evolution
openaire +3 more sources
Comparative analysis of synteny and functional divergence of APX genes in Fragaria vesca and Fragaria×ananassa. [PDF]
Lu S+7 more
europepmc +1 more source
GENETIC STUDIES OF BARLEY CROSSES INVOLVING TWO BRACHYTIC GENES
Ryûhei Takahashi, Jiro Hayashi
openalex +2 more sources
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini+10 more
wiley +1 more source
Single-cell sequencing combined with bulk RNA seq reveals the roles of natural killer cell in prognosis and immunotherapy of hepatocellular carcinoma. [PDF]
Wu J, Yang F, Huang G.
europepmc +1 more source